Krivox operates a cross-border advisory platform for medical second opinions, connecting patients in emerging markets with vetted US board-certified physicians.
Patients in emerging markets often lack a structured way to access specialist input on complex cases. Apex Opinion connects these patients with vetted US board-certified physicians who review medical records and prepare an advisory second opinion report. The platform is designed for cross-border care across geographies.
Specialist second opinions can help refine clinical understanding, but most patients in emerging markets have no structured way to access one. Current pathways are fragmented, informal, and inconsistent.
Patients submit medical records. The platform matches the case to a vetted US board-certified specialist. The specialist reviews the materials and prepares a written advisory second opinion report, typically within 5 to 7 business days.
Patients upload their medical records securely. A US board-certified specialist on the Apex Opinion network reviews the case and prepares an advisory second opinion report, typically within 5 to 7 business days.
Apex Opinion is in development, with public launch planned for 2026. We are building a physician panel across core specialties.
Apex Opinion is building a selective panel of US board-certified specialists. We are selective by design: every physician on the panel reflects the clinical standard our users depend on. If you are accepted, you review cases remotely, on your own schedule, from anywhere. No overhead. No insurance paperwork. No payer negotiations. Just clinical work that pays well, deposited directly.